Yong Li

4.5k total citations · 1 hit paper
198 papers, 2.7k citations indexed

About

Yong Li is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yong Li has authored 198 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Surgery, 80 papers in Pulmonary and Respiratory Medicine and 54 papers in Oncology. Recurrent topics in Yong Li's work include Gastric Cancer Management and Outcomes (53 papers), Esophageal Cancer Research and Treatment (25 papers) and Gastrointestinal Tumor Research and Treatment (24 papers). Yong Li is often cited by papers focused on Gastric Cancer Management and Outcomes (53 papers), Esophageal Cancer Research and Treatment (25 papers) and Gastrointestinal Tumor Research and Treatment (24 papers). Yong Li collaborates with scholars based in China, United States and Japan. Yong Li's co-authors include Carolyn W. Gibson, Shaoxu Wu, Junjiong Zheng, Tianxin Lin, Jian Huang, Siya Shi, Hao Yu, Yangfan Su, Weibin Xie and Ashok B. Kulkarni and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Yong Li

183 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer

2017 313 citations Shaoxu Wu, Junjiong Zheng et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yong Li China	27	780	703	689	610	485	198	2.7k
Woong Kyu Han South Korea	27	1.1k 1.4×	612 0.9×	1.5k 2.2×	184 0.3×	183 0.4×	173	2.5k
Giovanni Battista Doglietto Italy	33	1.6k 2.0×	592 0.8×	955 1.4×	1.2k 2.0×	476 1.0×	119	3.4k
Eiji Takeuchi Japan	29	1.1k 1.4×	693 1.0×	904 1.3×	543 0.9×	415 0.9×	241	3.3k
Andrew P. Zbar Israel	31	1.8k 2.2×	352 0.5×	457 0.7×	1.1k 1.9×	833 1.7×	140	3.0k
Constantin A Dasanu United States	26	462 0.6×	453 0.6×	397 0.6×	873 1.4×	122 0.3×	208	2.4k
P B Boulos United Kingdom	31	1.4k 1.8×	295 0.4×	670 1.0×	930 1.5×	240 0.5×	99	2.9k
Alexandros Polychronidis Greece	28	1.1k 1.4×	721 1.0×	688 1.0×	615 1.0×	116 0.2×	102	2.5k
Stephen R.T. Evans United States	31	692 0.9×	567 0.8×	497 0.7×	582 1.0×	692 1.4×	77	3.3k
David A. Rodeberg United States	35	1.2k 1.5×	574 0.8×	2.5k 3.6×	867 1.4×	726 1.5×	114	3.7k
David H. Wang United States	29	1.4k 1.7×	1.0k 1.5×	469 0.7×	507 0.8×	407 0.8×	71	3.1k

Countries citing papers authored by Yong Li

Since Specialization

Citations

This map shows the geographic impact of Yong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Li more than expected).

Fields of papers citing papers by Yong Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Li. The network helps show where Yong Li may publish in the future.

Co-authorship network of co-authors of Yong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Li. A scholar is included among the top collaborators of Yong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Li. Yong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yucheng, et al.. (2025). Clonal Hematopoiesis of Indeterminate Potential as a Predictor of Colorectal Cancer Risk: Insights from the UK Biobank Cohort. Cancer Epidemiology Biomarkers & Prevention. 34(3). 405–411. 3 indexed citations

Xu, Xiayi, et al.. (2025). Fluidic microgel assemblies with enhanced oral delivery of biologics alleviate colonic inflammation in murine and canine models. Science Advances. 11(50). eadv6994–eadv6994.

Zhu, Dandan, et al.. (2024). DEPDC1B: A novel tumor suppressor gene associated with immune infiltration in colon adenocarcinoma. Cancer Medicine. 13(15). e70043–e70043. 1 indexed citations

Zheng, Jiabin, Jiatong Lin, Yucheng Zhang, et al.. (2024). KDM3A Ablation Activates Endogenous Retrovirus Expression to Stimulate Antitumor Immunity in Gastric Cancer. Advanced Science. 11(40). e2309983–e2309983. 6 indexed citations

Qiu, Haibo, Zhiwei Zhou, Ye Zhou, et al.. (2024). Updated efficacy results of olverembatinib (HQP1351) in patients with tyrosine kinase inhibitor (TKI)-resistant succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumors (GIST) and paraganglioma.. Journal of Clinical Oncology. 42(16_suppl). 11502–11502. 9 indexed citations

Yu, Nuo, Jiao Li, Jianjun Qin, et al.. (2024). Efficacy and safety of the combination of tisleizumab with chemoradiotherapy in oligorecurrence esophageal squamous cell carcinoma: A prospective phase II study.. Journal of Clinical Oncology. 42(16_suppl). 4057–4057. 1 indexed citations

Chen, Jierong, Yiqi Li, Zhi Li, et al.. (2024). Comparative single-cell analysis reveals heterogeneous immune landscapes in adenocarcinoma of the esophagogastric junction and gastric adenocarcinoma. Cell Death and Disease. 15(1). 15–15. 7 indexed citations

Yao, Weiwei, Yucheng Zhang, Yongfeng Liu, et al.. (2024). LGALS9B stabilizes EEF1D protein and activates the PI3K/AKT signaling pathway to promote gastric cancer occurrence and metastasis. Oncogene. 44(10). 652–664.

Wang, Junjiang, et al.. (2024). Predicting the surgical benefit of primary tumor resection in patients with stage IV colorectal cancer. Asian Journal of Surgery. 47(11). 4735–4743.

10.

Sun, Qi, Yang Li, Ruijun Xu, et al.. (2023). Hydrogel Encapsulating Wormwood Essential Oil with Broad‐spectrum Antibacterial and Immunomodulatory Properties for Infected Diabetic Wound Healing. Advanced Science. 11(3). e2305078–e2305078. 18 indexed citations

11.

Zhu, Dandan, et al.. (2023). Comprehensive analysis of HOXC8 associated with tumor microenvironment characteristics in colorectal cancer. Heliyon. 9(11). e21346–e21346. 5 indexed citations

12.

Zhang, Ruixiang, Canjun Li, Zhiyi Wan, et al.. (2023). Comparative genomic analysis of esophageal squamous cell carcinoma among different geographic regions. Frontiers in Oncology. 12. 999424–999424. 1 indexed citations

13.

Hu, Weixian, Renjie Li, Xingyu Feng, et al.. (2020). <p>Retroperitoneal Extragastrointestinal Stromal Tumors Have a Poor Survival Outcome: A Multicenter Observational Study</p>. Cancer Management and Research. Volume 12. 10491–10504. 10 indexed citations

14.

Wu, Shaoxu, Junjiong Zheng, Yong Li, et al.. (2017). A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer. Clinical Cancer Research. 23(22). 6904–6911. 313 indexed citations breakdown →

15.

Wang, Junjiang, et al.. (2017). [Discussion on standardized implementation of laparoscopic radical lymphadenectomy for distal gastric cancer].. PubMed. 20(8). 857–861. 1 indexed citations

16.

Yang, Zifeng, Junjiang Wang, Deqing Wu, Jiabin Zheng, & Yong Li. (2017). Retrospectively analysis of the pathology and prognosis of 131 cases of adenocarcinoma of the esophagogastric junction (Siewert type II/III). Translational Cancer Research. 6(5). 949–959.

17.

Cheng, Fang, Wei Wang, Yu Zhang, et al.. (2016). [Clinicopathological features and prognosis of patients with gastric neuroendocrine carcinoma from multiple centers in southern China].. PubMed. 19(11). 1230–1234. 2 indexed citations

18.

Hazel‐Fernandez, Leslie, et al.. (2015). Relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries.. PubMed. 21(1). e62–70. 23 indexed citations

19.

Lu, Ligong, et al.. (2012). Clinical observation of transcatheter arterial chemoembolization combined with sorafenib on intermediate-advanced hepatocellular carcinoma. Zhonghua fangshexian yixue zazhi. 46(3). 252–256. 4 indexed citations

20.

Hou, Xiang‐Yu, Lingyun Wang, Weilin Wang, Yong Li, & Yuzuo Bai. (2011). [Clinical significance of detection of internal anal sphincter in children with functional constipation].. PubMed. 14(10). 753–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact